Adam M. Spivak

Adam M. Spivak, MD, is an Associate Professor in the Department of Internal Medicine at the University of Utah. He serves as Medical Director of the HIV Clinic and leads translational research on HIV persistence and eradication, with a focus on latency reversal agents and aging in HIV patients. He co-founded Utah's first free HIV prevention clinic and is a scientific member of the NIH AIDS Clinical Trial Group (ACTG).

Education:

• MD from University of Maryland School of Medicine
• A.B. in English Literature from Princeton University
• Residency and Fellowship at Johns Hopkins Hospital

Research Interests:
Dr. Spivak investigates HIV latency reversal, tyrosine kinase inhibitors, and long-term effects of HIV and SARS-CoV-2. His work spans molecular mechanisms, clinical trials, and health equity initiatives, particularly in transgender populations.

Scientific Awards:

• Fellow of the American College of Physicians (FACP)

Advising and Leadership:
He teaches at the University of Utah School of Medicine, mentors post-graduate trainees, and leads interventional clinical trials in the ACTG network. His research bridges infectious diseases, pharmacology, and health equity.